 The shares of Vaxart Inc NASDAQ:VXRT are up 7.2 at 7.71 this morning, following news that the U.S. Food and Drug Administration FDA cleared the drug maker to start a clinical trial for its S-only oral tablet Covid-19 vaccine candidate. 